vs
Side-by-side financial comparison of CANADIAN IMPERIAL BANK OF COMMERCE (CM) and Fresenius Medical Care AG (FMS). Click either name above to swap in a different company.
CANADIAN IMPERIAL BANK OF COMMERCE is the larger business by last-quarter revenue ($6.1B vs $5.5B, roughly 1.1× Fresenius Medical Care AG). CANADIAN IMPERIAL BANK OF COMMERCE runs the higher net margin — 36.9% vs 7.9%, a 29.0% gap on every dollar of revenue.
The Imperial Bank of Canada was a Canadian bank that operated from 1873 to 1961. In 1961, Imperial merged with the Canadian Bank of Commerce to become the Canadian Imperial Bank of Commerce.
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo dialysis 3 times per week for the rest of their lives.
CM vs FMS — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $6.1B | $5.5B |
| Net Profit | $2.3B | $434.2M |
| Gross Margin | — | 27.4% |
| Operating Margin | — | 11.7% |
| Net Margin | 36.9% | 7.9% |
| Revenue YoY | — | -0.3% |
| Net Profit YoY | — | 240.4% |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $6.1B | — | ||
| Q4 25 | — | $5.5B | ||
| Q3 25 | $5.3B | — | ||
| Q2 25 | $5.1B | — | ||
| Q4 24 | — | $5.5B |
| Q1 26 | $2.3B | — | ||
| Q4 25 | — | $434.2M | ||
| Q3 25 | $1.5B | — | ||
| Q2 25 | $1.5B | — | ||
| Q4 24 | — | $127.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | 27.4% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q4 24 | — | 25.0% |
| Q1 26 | — | — | ||
| Q4 25 | — | 11.7% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q4 24 | — | 5.1% |
| Q1 26 | 36.9% | — | ||
| Q4 25 | — | 7.9% | ||
| Q3 25 | 28.9% | — | ||
| Q2 25 | 28.6% | — | ||
| Q4 24 | — | 2.3% |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.0B | $1.7B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $47.9B | $15.4B |
| Total Assets | $826.8B | $33.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $8.0B | — | ||
| Q4 25 | — | $1.7B | ||
| Q3 25 | $13.9B | — | ||
| Q2 25 | $10.2B | — | ||
| Q4 24 | — | $1.3B |
| Q1 26 | $47.9B | — | ||
| Q4 25 | — | $15.4B | ||
| Q3 25 | $45.9B | — | ||
| Q2 25 | $45.2B | — | ||
| Q4 24 | — | $17.0B |
| Q1 26 | $826.8B | — | ||
| Q4 25 | — | $33.5B | ||
| Q3 25 | $804.6B | — | ||
| Q2 25 | $795.8B | — | ||
| Q4 24 | — | $36.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.6B | $2.9B |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | -0.69× | 6.67× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $-1.6B | — | ||
| Q4 25 | — | $2.9B | ||
| Q3 25 | $4.3B | — | ||
| Q2 25 | $667.2M | — | ||
| Q4 24 | — | $2.6B |
| Q1 26 | -0.69× | — | ||
| Q4 25 | — | 6.67× | ||
| Q3 25 | 2.80× | — | ||
| Q2 25 | 0.46× | — | ||
| Q4 24 | — | 20.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
